NBY  Novabay Pharmaceuticals Inc.

Exchange

AMEX

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

42.53M

Vuru Grade

31.66/100

Current Price

$3.78
+0.13 (+3.56%)

Company Metrics

  • P/E 0
  • P/S 5.69
  • P/B 27.9
  • EPS -3.87
  • Cash ROIC 921.20%
  • Cash Ratio 0.51
  • Dividend 0 / 0%
  • Avg. Vol. 110,734.00
  • Shares 2.78M
  • Market Cap. 42.53M

Company Description

NovaBay Pharmaceuticals Inc., a clinical stage biotechnology company, engages in developing proprietary and patented topical Aganocide compounds for the treatment and prevention of various infections without causing bacterial resistance. Its Aganocide compounds are synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white bloo... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Where Does NovaBay Pharmaceuticals, Inc. (NYSEMKT: NBY) Have Its Focus This Year?
Scibility Media - Aug 15, 2016
NovaBay Pharmaceuticals, Inc. (NYSEMKT: NBY) has set for itself many targets to hit before the end of 2016. But there is one that the management of the company has been talking about repeatedly: achieving positive cash flow.
Biotech Stocks Worth Chasing: Sangamo Biosciences Inc. (SGMO), NovaBay ... - Zergwatch
Investor's Alert: NovaBay Pharmaceuticals, Inc. (NBY), Emerson Electric Co ... - iStreetWire
News NovaBay Pharmaceuticals Inc.NBY
Wall Street Journal - Feb 11, 2011
News NovaBay Pharmaceuticals Inc.NBY. Significant News Only. 08/11/16; Press Release. NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results.
NovaBay Pharmaceuticals Inc.
MarketWatch - Jul 16, 2010
NovaBay Pharmaceuticals Inc. NYSE MKT: NBY. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
18 Biggest Mid-Day Gainers For Friday
Benzinga - Aug 12, 2016
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) shares climbed 30.4 percent to $3.20 following Q2 results. NovaBay Pharma reported a Q2 loss of $0.36 per share on revenue of $2.7 million.
NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results
Business Wire (press release) - Aug 11, 2016
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova lid and lash hygiene product for the domestic eye care market, reports financial results for the three ...
NovaBay Pharma (NBY) Issues Quarterly Earnings Results - BBNS
Could NovaBay Pharmaceuticals, Inc. See a Reversal After This Very Strong Session?
Press Telegraph - Aug 22, 2016
The stock of NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) is a huge mover today! The stock increased 3.40% or $0.12 on August 22, hitting $3.65.
NovaBay Pharma (NBY) Names Mark Sieczkarek as Permanent CEO
StreetInsider.com - Jun 13, 2016
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) announces the appointment of Mark M. Sieczkarek as President and Chief Executive Officer, effectively immediately.
NovaBay Pharmaceuticals Announces Restructuring to Focus on Avenova ...
Business Wire (press release) - Nov 19, 2015
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY) announces a corporate restructuring to focus on the commercialization of its prescription Avenova┬« Lid and Lash Cleanser. NovaBay is also taking steps to reduce operating expenses ...
Hot Stock Alert - NovaBay Pharmaceuticals, Inc.'s (NBY)
Hot Stocks Point - Aug 17, 2016
NovaBay Pharmaceuticals, Inc.'s (NBY), a part of Healthcare sector and belongs to Biotechnology industry; ended its day with a loss of -7.80% and finalized at the price of $3.90.
Biotechnology Stocks Making Notable Moves: Amgen Inc. (NASDAQ:AMGN), NovaBay ... - Street Wise Report (press release) (blog)
NovaBay Pharmaceuticals Announces Agreement for Nearly $12 Million in Two ...
Business Wire (press release) - Apr 6, 2016
BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY) a biopharmaceutical company focusing on commercializing its Avenova┬« Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into a securities purchase ...
NovaBay to Raise $11.8 Mln in Private Placement of Stock, Warrants - Nasdaq